Skip to Main Content

Paper Details

Broadly neutralizing antibodies target the coronavirus fusion peptide.
bioRxiv
6
2022
BA.2, COV44, COV44-, COV44-62, COV44-79, COVID-19, Fabs, S2, SARS, SARS-, SARS-CoV, SARS-CoV-2, SARS-CoV-2 fusion peptide, alpha, arginine, coronavirus, coronavirus fusion peptide, fusion peptide, human, spike
Author NameAffiliation
Lingshu WangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
John R MascolaVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Ian A WilsonScripps Research Institute
Ian A WilsonThe Skaggs Institute for Chemical Biology, The Scripps Research Institute
  • 1 - 4

Datasets

Release 1.2